Abstract:

COVID-19 epidemic is a significant risk in this population because dialytic patients are older and often have significant complications such as cardiovascular disease, diabetes and cerebrovascular disease. In chronic kidney patients, the dysfunction of lymphocytes and granulocytes due to the uric environment leads to an immune system disorder and infections can bring more negative clinical results in dialytic patients. In many comprehensive observation studies, COVID-19 is more common among patients with hemodialysis (HD) and the infection is more fatal in this patient's cohorte. There are recommendations from many nefrological associations for the prevention, relief and control of SARS-CoV-2 pandemic (COVID-19) that occurs in hemodialysis centers. To minimize COVID-19 infection in kidney patients, methods such as peritonal dialysis and home HD stands before us as a attractive, alternative method. A significant proportion of HD patients with COVID-19 may not develop symptoms. This situation stands in front of us as a serious problem that can lead to delay in diagnosis and epidemic within the center.

Keywords: